Abbott’s medical device and diagnostic sales in the second quarter of 2021 not only recovered from the worst days of the pandemic in 2020, but exceeded pre-pandemic levels.
The company’s medical device sales totaled $3.67bn in the second quarter, representing a 45.1% year-over-year increase on an organic basis, Abbott reported on 22 July.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?